Sedation for Pacing in Patients with Heart Failure or Coronary Artery Disease

Recommended Sedation Approach

• The European Society of Cardiology recommends using fentanyl as the first-line agent, with midazolam as the adjunctive sedative if deeper sedation is required, for patients with heart failure or coronary artery disease undergoing pacing procedures 1
• Fentanyl provides neutral effects on coronary vasomotion, reduces myocardial oxygen consumption, and does not cause coronary steal phenomenon in ischemic hearts 1
• In patients with heart failure, opioids maintain cardiac output and provide hemodynamic stability with minimal negative inotropic effects 1
• The European Heart Journal suggests adding midazolam if fentanyl alone provides inadequate sedation, with a recommended dose of 2-5 mg boluses as needed 2, 3

Hemodynamic Rationale

• Benzodiazepines produce a "nitroglycerin-like effect" by reducing cardiac filling pressures without compromising coronary blood flow 5
• They do not promote myocardial ischemia and may actually increase coronary blood flow while decreasing oxygen consumption in ischemic hearts 1, 6

Critical Warnings About Propofol

• The European Heart Journal recommends avoiding propofol in patients with severe heart failure, cardiogenic shock, or large areas of myocardial ischemia due to its severe hemodynamic instability 1, 4
• Propofol causes severe hemodynamic instability in heart failure patients, with reports of refractory cardiogenic shock 1

Dexmedetomidine Considerations

• The European Heart Journal suggests avoiding dexmedetomidine during the acute pacing procedure in hemodynamically unstable patients due to its potential to cause bradycardia and hypotension 1, 2
• Dexmedetomidine has been associated with refractory cardiogenic shock in vulnerable patients 1

Practical Dosing Algorithm

• The European Heart Journal recommends administering fentanyl 25-100 μg IV bolus slowly, followed by assessment of sedation level and potential addition of midazolam 1-2 mg IV bolus if needed 2, 3

Common Pitfalls to Avoid

• The European Society of Cardiology warns against using rapid bolus administration in elderly or hemodynamically unstable patients, and assuming propofol is safer due to its short half-life 1, 4
• The European Heart Journal advises against using morphine concurrently with antiplatelet agents, and watching for accumulation of midazolam's active metabolite in renal dysfunction 1, 2